Platelet Inhibition by Valsartan and Valeryl 4-hydroxy Valsartan: A Possible Missing Link to Explain Benefits of Angiotensin II Receptor Blockers in Patients After Acute Vascular Events - Serebruany, VL; Malinin, A, I; Lowry, DR (J Cardiovasc Pharm, 2004)
et al.